AG
NVAX icon

Algert Global’s Novavax NVAX Stock Holding History

Algert Global’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Buy
+277,990
New +$2.49M 0.03% 773
2025
Q2 		– Sell
-16,690
Closed -$107K – 1295
2025
Q1 		$107K Buy
+16,690
New +$138K ﹤0.01% 1128
2024
Q3 		– Sell
-12,701
Closed -$161K – 1450
2024
Q2 		$161K Buy
+12,701
New +$128K 0.01% 1321
2022
Q3 		– Sell
-15,160
Closed -$780K – 1276
2022
Q2 		$780K Buy
+15,160
New +$785K 0.06% 580

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Algert Global's NVAX Position: Q2 2026 in Review

Algert Global opened a new position in Novavax (NVAX) in Q2 2026: 277,990 shares worth $2.62M. The stake represents 0.03% of the portfolio and ranks #773 among its holdings. This is a return to the name: Algert Global previously reported a position in NVAX as recently as Q1 2025.

Algert Global first reported a position in NVAX in Q2 2022 and has held it in 4 quarters since. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Algert Global held 277,990 shares of Novavax worth $2.62M as of Q2 2026.
  • Novavax was a new Algert Global position in Q2 2026.
  • Novavax made up 0.03% of Algert Global's portfolio in Q2 2026, its #773 holding.
  • Algert Global first reported a position in Novavax in Q2 2022 and has held it in 4 quarters since.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.